Maternal iron deficiency perturbs embryonic cardiovascular development in mice.
Jacinta I Kalisch-SmithNikita VedDorota SzumskaJacob E MunroMichael TroupShelley E HarrisHelena Rodriguez-CaroAimée JacquemotJack J J J MillerEleanor M StuartMagda WolnaEmily HardmanFabrice PrinEva Lana-ElolaRifdat AoidiElizabeth M C FisherVictor L J TybulewiczTimothy J MohunSamira Lakhal-LittletonSarah De ValEleni GiannoulatouDuncan Burnaby SparrowPublished in: Nature communications (2021)
Congenital heart disease (CHD) is the most common class of human birth defects, with a prevalence of 0.9% of births. However, two-thirds of cases have an unknown cause, and many of these are thought to be caused by in utero exposure to environmental teratogens. Here we identify a potential teratogen causing CHD in mice: maternal iron deficiency (ID). We show that maternal ID in mice causes severe cardiovascular defects in the offspring. These defects likely arise from increased retinoic acid signalling in ID embryos. The defects can be prevented by iron administration in early pregnancy. It has also been proposed that teratogen exposure may potentiate the effects of genetic predisposition to CHD through gene-environment interaction. Here we show that maternal ID increases the severity of heart and craniofacial defects in a mouse model of Down syndrome. It will be important to understand if the effects of maternal ID seen here in mice may have clinical implications for women.
Keyphrases
- iron deficiency
- pregnancy outcomes
- birth weight
- high fat diet induced
- congenital heart disease
- gestational age
- mouse model
- endothelial cells
- pregnant women
- genome wide
- copy number
- dna methylation
- type diabetes
- weight gain
- gene expression
- insulin resistance
- risk factors
- wild type
- polycystic ovary syndrome
- transcription factor
- high fat diet
- metabolic syndrome
- induced pluripotent stem cells
- breast cancer risk